Hongxia Sun, MD, PhD
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Hongxia Sun
I am a surgical and breast pathologist, and a board certified cytopathologist. I joined the Department of Pathology at The University of Texas MD Anderson Cancer Center in 2023, with a clinical focus on breast pathology. I have background and interest in basic and clinical cancer research. My current research focuses on diagnostic breast pathology, morphological, immunohistochemical, and molecular studies of various breast tumors, and clinical trials on breast cancer treatment.
Present Title & Affiliation
Primary Appointment
Patient Safety Quality Officer, Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associated Professor, Pathology, The University of Texas MD Anderson Cancer Center
Dual/Joint/Adjunct Appointment
Associate Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2002 | Peking Union Medical College, Beijing, CN, Biochemistry and Molecular Biology, Ph.D |
| 1999 | Hebei Medical University, Shijiazhuang, CN, Biochemistry and Molecular Biology, M.S |
| 1996 | Hebei Medical University, Shijiazhuang, CN, MD |
Postgraduate Training
| 2018-2019 | Clinical Fellowship, Breast Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2017-2018 | Clinical Fellowship, Oncologic Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2016-2017 | Clinical Fellowship, Cytopathology, Baylor College of Medicine, Houston, Texas |
| 2012-2016 | Clinical Residency, Anatomic and Clinical Pathology, The University of Texas Health Science Center McGovern Medical School, Houston, Texas |
| 2002-2007 | Research Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas |
Licenses & Certifications
| 2019 | Texas Medical Board |
| 2017 | American Board of Pathology, Cytopathology |
| 2016 | Pennsylvania Medical Physician and Surgeon |
| 2016 | American Board of Pathology, Anatomic and Clinical Pathology |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - 2025
Assistant Professor, Pathology/Laboratory Medicine, The University of Texas Health Science Center McGovern Medical School, Houston, TX, 2019 - 2022
Administrative Appointments/Responsibilities
Patient Safety Quality Officer, Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Associate Patient Safety Quality Officer, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - 2025
Medical Director, Harris Health System Squatty Lyons and Baytown Health Center Laboratories, Houston, TX, 2022 - 2022
Extramural Institutional Committee Activities
Member, The University of Texas MD Anderson Cancer Center Utilization Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, The University of Texas Health Science Center McGovern Medical School Research Committee, The University of Texas Health Science Center at Houston, 2021 - 2022
Member, Harris Health System LBJ Hospital Procedure Case Review Committee, The University of Texas Health Science Center at Houston, 2020 - 2022
Honors & Awards
| 2026 - Present | Shirley Stein Scientific Achievement Endowment Award, The University of Texas MD Anderson Cancer Center |
| 2025 - 2026 | Divisional Research Mentorship Award, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center |
| 2021 - 2022 | Harris County Hospital District Small Grants Award, Harris Health System |
| 2016 | Third Prize Award, pathology abstract platform presentation, Texas Society of Pathologist, 95th Annual Meeting |
| 2016 | Third Prize Award, pathology abstract platform presentation, United States & Canadian Academy of Pathology, 105th Annual Meeting |
| 2013 - 2016 | Resident Research Award, Department of Pathology and Laboratory Medicine at The University of Texas Health Science Center McGovern Medical School at Houston |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Pathology Perspective of HER2-low Breast Cancer: Challenges and Opportunities. Conference. The University of Texas MD Anderson Cancer Center Diagnostic Pathology Updates Conference 2023. Houston, TX, US.
- 2022. Breast Cancer Studies – From Tumor Immune System to Deep Learning Technology. Invited. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2024. Uncommon Invasive Breast Carcinoma: Pathological Features and Biomarker Study. Invited. Pathology Grand Rounds. Galveston, Texas, US.
- 2022. Predicting Breast Cancer Metastasis in Sentinel Lymph Node with Deep Learning Technology. Conference. Texas Society of Pathology 101th Annual Meeting. Houston, TX, US.
- 2018. Papillary Lesions of Breast. Invited. The University of Texas Health Science Center McGovern Medical School. Houston, TX, US.
National Presentations
- 2024. High Risk-associated Breast Lesions: Diagnosis and Clinical Management. Invited. Chinese American Pathologists Association Online Education Program, US.
- 2018. Studies on Breast Cancer. Invited. Emory University. Atlanta, GA, US.
International Presentations
- 2022. Special Types of Invasive Breast Carcinoma. Invited. Phase I of the Breast Pathology Diagnosis and Improving Program in Hebei Province, CN.
- 2016. Reproducible Evaluation of Tumor-Infiltrating Lymphocytes (TILs) Using the Recommendations of International TILs Working Group 2014. Conference. United States & Canadian Academy of Pathology, 105th Annual Meeting. Seattle, US.
Grant & Contract Support
| Date: | 2026 - Present |
| Title: | Artificial Intelligence-Assisted Evaluation of Hormone Receptor Status in Residual HER2-Positive Breast Carcinoma After Neoadjuvant HER2-Targeted Therapy |
| Funding Source: | Shirley Stein Scientific Achievement Endowment Award, The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2025 - 2026 |
| Title: | Expression of FOXA1 as a Novel Potential Marker for Breast Neuroendocrine Neoplasms |
| Funding Source: | Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center |
| Role: | Mentor |
| Date: | 2023 - 2024 |
| Title: | Potential Utility of Artificial Intelligence Solutions for Accurate Interpretation of HER2 Immunostain in Breast Cancer HER2 EEP Study |
| Funding Source: | Ibex Medical Analytics |
| Role: | Co-I |
| Date: | 2023 - 2025 |
| Title: | Exploring the Nature of Malignant Phyllodes Tumor with Comparison to Metaplastic Breast Carcinoma and Primary Breast Sarcoma |
| Funding Source: | 2023 Andrew Sabin Family Fellowship Award |
| Role: | Co-I |
| Date: | 2021 - 2022 |
| Title: | Defining Immunophenotypes of Breast Ductal Carcinoma In Situ in Black Women |
| Funding Source: | MD Anderson Quasi Endowment Community Outreach and Engagement Fund |
| Role: | Co-PI |
| Date: | 2021 - 2022 |
| Title: | Siglecs Expression in Breast Cancer and its Association with PD-1, PD-L1, and Patient Clinical Outcome |
| Funding Source: | Harris County Hospital District Small Grants |
| Role: | PI |
| Date: | 2019 - 2022 |
| Title: | faculty start-up funds |
| Funding Source: | Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center McGovern Medical School |
| Role: | PI |
| Date: | 2013 - 2016 |
| Title: | The Role of CD8+ Cytotoxic and FOXP3 Regulatory T cell Infiltration in Breast Cancer Tissue and Sentinel Lymph Nodes and Their Association with SIRT1 |
| Funding Source: | Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center McGovern Medical School |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Han, J, Ding, Y, Gan, Q, Sweeney, K, Huang, X, Hameed, N, Weissferdt, A, Wang, Y, Peng, Y, Sun, H. TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms. Human Pathology 177, 2026. e-Pub 2026. PMID: 42398545.
- Symmans WSO, Tran K, Fu C, Sun H, Gould R, Pusztai L, King T, Salgado R, Valero V, Symmans WF, Andreopoulou E. Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer. npj Breast Cancer. e-Pub 2026.
- Ye Q, Estrella J, Kalhor N, Liu A, Han C, Sun H, Middleton LP, Chen H, Albarracin C, Sahin A, Wu Y, Ding Q. TRPS1 Expression in Neuroendocrine Neoplasms of Breast and Other Organs. Histopathology 88(2):524-532, 2026. e-Pub 2026. PMID: 41025885.
- Korie U, Ai D, Podany P, Zhang H, Zhan H, Kahila M, Colon-Cartagena L, Wei S, Sun H, Du J, Krishnamurti U, Liang Y. Interobserver Agreement and Histologic Analysis of Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ, a Multi-institutional Study. Am J Surg Pathol 164(5):704-711, 2025. e-Pub 2025. PMID: 40994034.
- Ding Q, Aung P, Sun H, Solis Soto LM, Lu W, Raso MG, Rizvi YQ, Wistuba II, Sahin AA, Prieto VG. Upregulation of MMP9 expression in post-radiation angiosarcoma of the breast: A possible predictive risk factor. Virchows Archiv 489(1):199-204, 2025. e-Pub 2025. PMID: 40335788.
- Ye, Q, Law, T, Klippel, D, Albarracin, C, Chen, H, Contreras, A, Ding, Q, Huo, L, Khazai, L, Middleton, LP, Resetkova, E, Sahin, AA, Sun, H, Sweeney, K, Symmans, WF, Wu, Y, Yoon, EC, Krishnamurthy, S. Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer. Modern Pathology 38(4), 2025. e-Pub 2025. PMID: 39788205.
- Thomas K, Trinh H, Fei A, Khazai L, Sun H, Gan Q. Cytologic features of angiosarcoma in fluid specimens: A retrospective study of 22 cases. Cancer Cytopathology 133(3), 2025. e-Pub 2025. PMID: 39992713.
- Gao Y, Ali H, Hu Z, Sun H. Sarcoid-like Reaction in Breast Cancer Tumor Bed and Axillary Lymph Nodes Following Neoadjuvant Chemotherapy: A Case Report. Ann Clin Lab Sci 55(2):281-285, 2025. e-Pub 2025. PMID: 40340873.
- Ye Q, Chen H, Han C, Peng Y, Huang X, Sun H, Wu Y, Albarracin CT, Middleton LP, Sahin AA, Huo L, Ding Q. Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma. J Clin Pathol 77(11):751-755, 2024. e-Pub 2024. PMID: 37586834.
- Batra H, Bose PSC, Zhang Y, Ding Y, Liu A, Chen H, Wu Y, Albarracin CT, Sun H, Sahin AA, Wistuba II, Raso MG, Yang F. MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancers. Histopathology 85(3):503-509, 2024. e-Pub 2024. PMID: 38973399.
- Sun H, Kang EY, Chen H, Sweeney KJ, Suchko M, Wu Y, Wen J, Krishnamurthy S, Albarracin CT, Ding QQ, Foo WC, Sahin AA. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis. Breast Cancer Res Treat 205(2):403-411, 2024. e-Pub 2024. PMID: 38441847.
- Wang J, Peng Y, Sun H, Aung PP, Resetkova E, Yam C, Sahin AA, Huo L, Ding Q. TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation. Arch Pathol Lab Med 148(2):200-205, 2024. e-Pub 2024. PMID: 37074839.
- Allam K, Wang XI, Zhang S, Ding J, Chiu K, Saluja K, Wahed A, Sun H, Nguyen AND. Deep Learning Provides Rapid Screen for Breast Cancer Metastasis with Sentinel Lymph Nodes. Ann Clin Lab Sci 53(6):819-824, 2024. e-Pub 2024. PMID: 38182154.
- Wang M, Ding Q, Gu J, Sfamenos SM, Huo L, Tang Z, Sun H, Robinson M, Tang G, Lim B, Wu Y, Albarracin CT, Sahin AA, Chen H. Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?. Clin Breast Cancer 23(4):415-422, 2023. e-Pub 2023. PMID: 36878823.
- Ali H, Moosvi AM, Zhang YH, Sun H. Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review. Ann Clin Lab Sci 53(1):159-163, 2023. e-Pub 2023. PMID: 36889758.
- Elzamly S, Al-Habib A, Toraih EA, Jani PP, Thomas-Ogunniyi J, Sun H, Liu J, Zhu H, Buryanek J, Guo T, Zhang S. The optimal approach of EBUS-FNA rapid on-site evaluation (ROSE): a five-year experience from a large academic medical center. J Am Soc Cytopathol 11(5):328-333, 2022. e-Pub 2022. PMID: 35842295.
- Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol 125:97-107, 2022. e-Pub 2022. PMID: 35413381.
- Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
- Luo W, Nagaria TS, Sun H, Ma J, Lombardo JL, Bassett R, Cao AC, Tan D. Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma. Pathol Oncol Res 28, 2022. e-Pub 2022. PMID: 35221802.
- Li R, Saluja K, Mai B, Covinsky M, Sun H. Cystic Encapsulated Papillary Carcinoma in the Male Breast: An Unusual Feature With a Diagnostic Challenge. Int J Surg Pathol 30(1):63-67, 2022. e-Pub 2022. PMID: 34304607.
- Sun H, Chen H, Crespo J, Tang G, Robinson M, Lim B, Sahin AA. Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy. Eur J Breast Health 17(2):128-136, 2021. e-Pub 2021. PMID: 33870112.
- Crespo J, Sun H, Wu J, Ding QQ, Tang G, Robinson MK, Chen H, Sahin AA, Lim B. Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy. PLoS One 15(11):e0241775, 2020. e-Pub 2020. PMID: 33180796.
- Sun H, Masand RP, Patel SJ, Padmanabhan V. High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test. Diagn Cytopathol 46(11):908-913, 2018. e-Pub 2018. PMID: 30488672.
- Kojima YA, Wang X, Sun H, Compton F, Covinsky M, Zhang S. Reproducible evaluation of tumor-infiltrating lymphocytes (TILs) using the recommendations of International TILs Working Group 2014. Ann Diagn Pathol 35:77-79, 2018. e-Pub 2018. PMID: 29886396.
- Tandon N, Sultana S, Sun H, Zhang S. Follicular Lymphoma Arising in a Mature Cystic Teratoma in a 26 Year Old Female. Ann Clin Lab Sci 46(3):298-301, 2016. e-Pub 2016. PMID: 27312556.
- Sun H, Yang M. An Unusual Variant of Hepatic Inflammatory Angiomyolipoma: Report of a Rare Entity. Ann Clin Lab Sci 46(1):78-82, 2016. e-Pub 2016. PMID: 26927347.
- Sun H, McGuire MF, Zhang S, Brown RE. NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates. Ann Clin Lab Sci 45(6):692-701, 2015. e-Pub 2015. PMID: 26663801.
- Aktas B, Sun H, Yao H, Shi W, Hubbard R, Zhang Y, Jiang T, Ononye SN, Wali VB, Pusztai L, Symmans WF, Hatzis C. Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue. Mol Oncol 8(3):717-27, 2014. e-Pub 2014. PMID: 24602449.
- Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, Wu Y, Pusztai L, Symmans WF. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J Natl Cancer Inst 103(24):1871-83, 2011. e-Pub 2011. PMID: 22034635.
- Chung WC, Ryu SH, Sun H, Zeldin DC, Koo JS. CREB mediates prostaglandin F2alpha-induced MUC5AC overexpression. J Immunol 182(4):2349-56, 2009. e-Pub 2009. PMID: 19201889.
- Sun H, Chung WC, Ryu SH, Ju Z, Tran HT, Kim E, Kurie JM, Koo JS. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis. Cancer Prev Res (Phila) 1(5):316-28, 2008. e-Pub 2008. PMID: 19138976.
- Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, Aldaz CM. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 5(9):881-90, 2007. e-Pub 2007. PMID: 17855657.
- Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A, Aldaz CM. Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics 6:37, 2005. e-Pub 2005. PMID: 15762987.
- Hu Y, Sun H, Drake J, Kittrell F, Abba MC, Deng L, Gaddis S, Sahin A, Baggerly K, Medina D, Aldaz CM. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res 64(21):7748-55, 2004. e-Pub 2004. PMID: 15520179.
- Liu Z, Sun HX, Zhang YW, Li YF, Zuo J, Meng Y, Fang FD. Effect of SNPs in protein kinase C zeta gene on gene expression in the reporter gene detection system. World J Gastroenterol 10(16):2357-60, 2004. e-Pub 2004. PMID: 15285019.
- Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res 6(5):R499-513, 2004. e-Pub 2004. PMID: 15318932.
- Li YF, Sun HX, Wu GD, Du WN, Zuo J, Shen Y, Qiang BQ, Yao ZJ, Wang H, Huang W, Chen Z, Xiong MM, Meng Y, Fang FD. Protein kinase C/zeta (PRKCZ) gene is associated with type 2 diabetes in Han population of North China and analysis of its haplotypes. World J Gastroenterol 9(9):2078-82, 2003. e-Pub 2003. PMID: 12970910.
- Hu YF, Ren ZY, Li YF, Sun HX, Chang YS, Su CB, Wang RZ, Zuo J, Fang FD. [Serial analysis of gene expression in the pituitary adenomas and para-tumor normal pituitary tissues]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(6):611-5, 2002. e-Pub 2002. PMID: 12905690.
- Sun HX, Du WN, Li YF, Zuo J, Wu GD, Shen Y, Qiang BQ, Yao ZJ, Hang JM, Luo HY, Wang H, Huang W, Chen Z, Fang FD. [Functional analysis of the single nucleotide polymorphisms in the PRKCZ gene]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(5):471-3, 2002. e-Pub 2002. PMID: 12905767.
- Sun HX, Du WN, Li YF, Zuo J, Wu GD, Shen Y, Qiang BQ, Yao ZJ, Hang JM, Luo HY, Wang H, Huang W, Chen Z, Fang FD. [Linkage disequilibrium analysis of the single nucleotide polymorphisms in the PRKCZ gene]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(5):474-80, 2002. e-Pub 2002. PMID: 12905768.
- Du WN, Sun HX, Wang H, Qiang BQ, Yao ZJ, Gu J, Xiong MM, Huang W, Chen Z, Zuo J, Hua XF, Gao W, Sun Q, Fang FD. [Fine mapping of susceptibility genes loci within chromosome 1 in Chinese Han families with type 2 diabetes]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(3):234-7, 2002. e-Pub 2002. PMID: 12905624.
- Sun HX, Zhang KX, Du WN, Shi JX, Jiang ZW, Zuo J, Huang W, Chen Z, Shen Y, Yao ZJ, Qiang BQ, Hang JM, Wang H, Fang FD. [Single nucleotide polymorphisms in CAPN10 gene of Chinese population and its correlation with type 2 diabetes mellitus in Han people of northern China]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(3):228-33, 2002. e-Pub 2002. PMID: 12905623.
- Sun HX, Du WN, Zuo J, Wu GD, Shi GB, Shen Y, Qiang BQ, Yao ZJ, Hang JM, Wang H, Huang W, Chen Z, Fang FD. [The association of two single nucleotide polymorphisms in PRKCZ and UTS2 respectively with type 2 diabetes in Han people of northern China]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(3):223-7, 2002. e-Pub 2002. PMID: 12905622.
- Sun HX, Zhang KX, Du WN, Shi JX, Jiang ZW, Sun H, Zuo J, Huang W, Chen Z, Shen Y, Yao ZJ, Qiang BQ, Fang FD. Single nucleotide polymorphisms in CAPN10 gene of Chinese people and its correlation with type 2 diabetes mellitus in Han people of northern China. Biomed Environ Sci 15(1):75-82, 2002. e-Pub 2002. PMID: 12046551.
- Han J, Ding Y, Hameed N, Weissferdt A, Sun H. TRPS1 and GATA3 Expression in SMARCA4 Deficient Malignant Neoplasms. United States & Canadian Academy of Pathology, 114th Annual Meeting.
Invited Articles
- Sun, H, Sahin, AA, Ding, Q. Updates on utility of immunohistochemistry in diagnosis of metastatic breast cancer. Human Pathology 162, 2025. e-Pub 2025. PMID: 40441446.
- Sun H, Ding Q, Sahin AA. Immunohistochemistry in the Diagnosis and Classification of Breast Tumors. Arch Pathol Lab Med 147(10):1119-1132, 2023. e-Pub 2023. PMID: 37490413.
Abstracts
- Krishnamurthy S, Marques RC, Borkowski P, Cates J, Shearon E, MacGrogan G, Ding Q, Chandra P, Morphew E, Yassin R, Sweeney K, Sun H, Riben M, Wheeler D, Globerson Y, Ziv R, Etoz S, Grinwald M, Vecsler M. Multicenter study evaluating the utility of AI-aided HER2 scoring in the clinically relevant categories. American Society of Clinical Oncology, 2024 Annual Meeting.
- Moosvi AM, Ali H, Zhang YH, Sun H. Malignant Phyllodes Tumor with Heterologous Rhabdomyosarcomatous Element: A Case Report. Texas Society of Pathology 101th Annual Meeting.
- Sun H, Zheng L, Huang X, Han C, Liu J, Wu Y, Ding Q. A Comparison of Three TRPS1 Antibodies in Detecting TRPS1 Expression in Breast Carcinoma and Ovarian Serous Carcinoma. United States & Canadian Academy of Pathology, 114th Annual Meeting.
- Sun H, Huo L, Sweeney K, Yu W, Middleton L, Khazai L, Wu Y, Chen H, Albarracin C, Sahin A, Ding Q. Sarcomatoid metaplastic carcinoma or sarcoma: immunohistochemical analysis of CK-negative or -minimal positive sarcomatoid breast tumors. 37th European Congress of Pathology.
- Raval P, Ding Q, Singh P, Alaaeddin Alrohaibani, Sun H, Ai D, Wanis K, Zhao M, Chen H, Valero V, Mac Gregor MC, Sahin A. HER2 Status Conversion in Residual Breast Carcinoma After Neoadjuvant HER2-Targeted Therapy in Patients with HER2-Positive Breast Cancer. United States and Canadian Academy of Pathology, 115th Annual Meeting.
- Xu H, Saluja K, Liang Y, Sun H, Zhou X, Guo T, Ai D. Distinct Developmental Origins of Invasive Mammary Paget Disease and Invasive Ductal Carcinoma Uncovered by Spatial Transcriptomics. United States and Canadian Academy of Pathology, 115th Annual Meeting.
- Fang A, Dai A, Ding C, Gan Q, Sun H. Breast Cancer Prognostic Biomarker Status and Tumor Histological Grade Contribute to Nodal Response Difference in ypT0/TisN0 and ypT0/TisN1-3 Patients. United States and Canadian Academy of Pathology, 115th Annual Meeting.
- Sun H, Gan Q, Sahin A, Ding Q. Biomarker status changes and their clinicopathologic correlates in residual breast carcinoma after neoadjuvant therapy. 38th European Congress of Pathology.
- Sun H, Huang R, Nguyen A. Transformation from Acute Myeloid Leukemia with Maturation to Pure Erythroid Leukemia: A Case Report. College of American Pathologist 2014 annual meeting.
- Sun H, Ro JY. Unclassified Mixed Germ Cell and Sex Cord-Stromal Tumor of Ovary: A Case Report. Texas Society of Pathologist 94th Annual Meeting.
- Sun H, Mcguire MF, Zhang S, Bhattacharjee MB, Brown RE. NUT Midline Carcinoma: Morphoproteomics and Ingenuity Pathway Analysis Implicate EZH2 and Provide Pharmacogenomic Options. Association of Clinical Scientists 135 annual meeting.
- Sun H, Li M, Gao Y, Hunter RL, Zhang S. CD8+ Cytotoxic Lymphocytes Depletion in Breast Cancer Comparing with Their Matched Normal Breast Tissue. American Society for Clinical Pathology 2015 annual meeting.
- Sun H, Yang M. An Unusual Variant of Hepatic Inflammatory Angiomyolipoma: Report of A Rare Entity Diagnosed on Biopsy. American Society for Clinical Pathology 2015 annual meeting.
- Compton F, Kojima Y, Sun H, Wang X, Covinsky M, Zhang S. Breast Cancer Tumor Stroma Ratio and Stroma Type are not associated with Hormone Receptor Status, Lymph Node Status and Tumor Grade. United States & Canadian Academy of Pathology, 105th Annual Meeting.
- Kojima Y, Compton F, Sun H, Wang X, Covinsky M, Zhang S. Reproducible Evaluation of Tumor-Infiltrating Lymphocytes (TILs) Using the Recommendations of International TILs Working Group 2014. United States & Canadian Academy of Pathology, 105th Annual Meeting.
- Sun H, Li M, Gao Y, Hunter RL, Zhang S. High Subcapsular CD4/CD8 Lymphocyte Ratio in the Positive Sentinel/Axillary Lymph Node in Breast Cancer. United States & Canadian Academy of Pathology, 105th Annual Meeting.
- Sun H, Masand R, Patel SJ, Padmanabhan V. High Grade Intraepithelial Lesion on High-risk HPV Negative Patients: Why We Still Need the Pap Test. United States & Canadian Academy of Pathology, 106th Annual Meeting.
- Sun H, Sahin A. Invasive Ductal Carcinoma of Breast with Apocrine Differentiation: Clinical-pathological Characteristics and Biomarker Features. Texas Society of Pathology 97th Annual Meeting.
- Sun H, Chen H, Lim B, Tang G, Robinson M, Sahin A. Clinical and Pathological Features of Breast Cancer with ' Polysomy' of Chromosome 17. San Antonio Breast Cancer Symposium.
- Sun H, Nassif B, Guray M, Ha M, Hunt K, Keita M, Kamate B, Keyomarsi K, Sahin A. Pathologic Discordance of African American and West African Breast Cancer Populations. United States & Canadian Academy of Pathology, 108th Annual Meeting.
- Shitawi M, Taha H, Elzamly S, Savariya B, Sun H. Hurthle Cell Follicular Carcinoma of the Thyroid Gland Evolving to Anaplastic Carcinoma in a Patient with History of Scrofula. Texas Society of Pathology 100th Annual Meeting.
- Zheng L, Nguyen N, Wang XI, Zhang S, Ding J, Sun H. Predicting Breast Cancer Metastasis in Sentinel Lymph Node with Deep Learning Technology. United States & Canadian Academy of Pathology, 111th Annual Meeting.
- Salem A, Albarracin CT, Sun H, Sahin A, Ding Q. TRPS1 and GATA3 Expression in Adenoid Cystic Carcinoma of the Breast. United States & Canadian Academy of Pathology, 111th Annual Meeting.
- Zheng L, Allam K, Nguyen N, Wang XI, Zhang S, Ding J, Wahed AM, Sun H. Predicting Breast Cancer Metastasis in Sentinel Lymph Node with Deep Learning Technology. Texas Society of Pathology 101th Annual Meeting.
- Taha H, Shitawi M, Sun H, Yu W, Zhang YH. A Rare Case of GLI1-Rearranged Mesenchymal Neoplasm of the Liver. Texas Society of Pathology 101th Annual Meeting.
- Shitawi M, Taha H, Elzamly S, Sun H. Invasive Breast Carcinoma with Osteoclast-like Giant Cells: Case Report. Texas Society of Pathology 101th Annual Meeting.
- Shirai S, Ricks E, Zhu H, Sun H. Endocrine Mucin-Producing Sweat Gland Carcinoma in a 63-Year-Old Male: A Case Report. Texas Society of Pathology 101th Annual Meeting.
- Al-Refai R, Perrier A, Ding Q, Huang X, Sun H, Di Ai, Hunt K, Lillemoe H, Sahin A. Clinicopathologic Features and Outcomes of Phyllodes Tumors in Women Under 40 Years: A Single-Institution Cohort of 286 Cases. United States and Canadian Academy of Pathology, 115th Annual Meeting.
- Sun H, Gan Q, Wang X, Zhang S. Siglec-15 expression in breast cancer and its association with clinical and pathological features. 37th European Congress of Pathology.
- Sun H, Karni RJ, Zhang S, French CA, Bhattacharjee MB. Mediastinal Mass in a 35-year-old Female: Report of NUT Midline Carcinoma with Detailed Pathologic Features and Molecular Diagnostic Confirmation. Texas Society of Pathologist 92nd Annual Meeting.
- Sun H, Hatzis C, Fu C, Avritsher R, Ahrar K, Tam A, Curley S, Yao H, Vauthey JN, Valero V, Booser D, Maru D, Hamilton S, Luthra R, Lau R, Gould RE, Pusztai L, Wallace M, Symmans WF. Effect of Host Organ RNA on Genomic Testing of Metastatic Breast cancer. United States & Canadian Academy of Pathology, 102nd Annual Meeting.
- Sun H, Zhang S. Two Cases of Subserosal Muciphages of Fallopian Tubes Associated with Pregnancy. College of American Pathologist 2013 annual meeting.
- Sun H, Zhang S. A Case of Gliomatosis Peritonei with Encephalitis Status Post Surgical Resection of Immature Ovarian Teratoma. College of American Pathologist 2013 annual meeting.
- Shakuntala M, Sun H, Li M, Hunter RL, Zhang S. The Association of Sentinel/Axillary Lymph Node Metastasis with Lymph Node Reactive Patterns and FOXP-3 Positive T Regulatory Cells in Breast Cancer. United States & Canadian Academy of Pathology, 103rd Annual Meeting.
- Sun H, Zhang S, Bhattacharjee MB, McGuire MF, Brown RE. NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates. United States & Canadian Academy of Pathology, 103rd Annual Meeting.
- Ali H, Hu Z, Sun H. Diffuse Sarcoidosis-like Granulomatous Change in Breast Cancer Tumor Bed after Neoadjuvant Chemotherapy: A Case Report. College of American Pathologists 2022 Annual Meeting.
- Gao Y, Hermann A, Ding J, Sun H, Zhao B, Hu Z, Zhang S. Thoracic/Lung SMARCA4 (BRG1)-deficient Malignant Neoplasm: A Case Series Showing Significant Morphological and Immunohistochemical Heterogeneity. Texas Society of Pathology 102th Annual Meeting.
- Sun H, Huo L, Sweeney KJ, Resetkova E, Chai S, Chen H, Albarracin CT, Wu Y, Ding Q. SMARCA4/BRG1 Deficiency in Breast Carcinoma by Immunohistochemistry Study. United States & Canadian Academy of Pathology, 113th Annual Meeting.
- Ye Q, Klippel D, Albarracin CT, Chen H, Contreras A, Ding Q, Huo L, Khazai L, Resetkova E, Sahin A, Sun H, Sweeney KJ, Symmans WF, Wu Y, Krishnamurthy S. A Prospective Study of Real Time Whole Slide Imaging of Frozen Sections for Intraoperative Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer. United States & Canadian Academy of Pathology, 110th Annual Meeting.
Book Chapters
- Sun H. In: Principle and Protocols of Medical Molecular Biology. Shanghai Public Science Press, 1999.
Patient Reviews
CV information above last modified September 17, 2026